Citigroup’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.2M | Buy |
789,574
+169,775
| +27% | +$14M | 0.03% | 556 |
|
|
2025
Q4 | $52.8M | Sell |
619,799
-252,268
| -29% | -$20.7M | 0.02% | 617 |
|
|
2025
Q3 | $67.8M | Sell |
872,067
-513,348
| -37% | -$40.1M | 0.03% | 512 |
|
|
2025
Q2 | $108M | Buy |
1,385,415
+361,986
| +35% | +$27M | 0.05% | 325 |
|
|
2025
Q1 | $74.2M | Buy |
1,023,429
+182,238
| +22% | +$13M | 0.04% | 415 |
|
|
2024
Q4 | $62.3M | Sell |
841,191
-154,689
| -16% | -$10.8M | 0.04% | 435 |
|
|
2024
Q3 | $65.7M | Buy |
995,880
+511,530
| +106% | +$37.2M | 0.04% | 407 |
|
|
2024
Q2 | $44.7M | Buy |
484,350
+133,945
| +38% | +$11.9M | 0.03% | 533 |
|
|
2024
Q1 | $33.5M | Sell |
350,405
-23,853
| -6% | -$2M | 0.02% | 656 |
|
|
2023
Q4 | $28.5M | Sell |
374,258
-51,283
| -12% | -$3.57M | 0.02% | 689 |
|
|
2023
Q3 | $29.5M | Sell |
425,541
-70,288
| -14% | -$5.65M | 0.02% | 611 |
|
|
2023
Q2 | $46.8M | Sell |
495,829
-29,362
| -6% | -$2.55M | 0.03% | 458 |
|
|
2023
Q1 | $43.4M | Buy |
525,191
+92,745
| +21% | +$7.29M | 0.03% | 457 |
|
|
2022
Q4 | $32.3M | Sell |
432,446
-18,566
| -4% | -$1.43M | 0.03% | 571 |
|
|
2022
Q3 | $37.3M | Buy |
451,012
+82,945
| +23% | +$7.98M | 0.03% | 484 |
|
|
2022
Q2 | $35M | Buy |
368,067
+41,990
| +13% | +$4.35M | 0.03% | 532 |
|
|
2022
Q1 | $38.4M | Sell |
326,077
-32,112
| -9% | -$3.6M | 0.02% | 604 |
|
|
2021
Q4 | $46.4M | Sell |
358,189
-13,677
| -4% | -$1.6M | 0.02% | 591 |
|
|
2021
Q3 | $42.1M | Sell |
371,866
-434,476
| -54% | -$49.6M | 0.02% | 612 |
|
|
2021
Q2 | $83.5M | Buy |
806,342
+242,022
| +43% | +$22.8M | 0.05% | 353 |
|
|
2021
Q1 | $47.2M | Sell |
564,320
-10,162
| -2% | -$859K | 0.03% | 515 |
|
|
2020
Q4 | $52.4M | Buy |
574,482
+100,892
| +21% | +$8.37M | 0.03% | 517 |
|
|
2020
Q3 | $37.8M | Sell |
473,590
-20,227
| -4% | -$1.58M | 0.02% | 582 |
|
|
2020
Q2 | $34.1M | Buy |
493,817
+204,998
| +71% | +$14.6M | 0.03% | 549 |
|
|
2020
Q1 | $18.2M | Sell |
288,819
-18,432
| -6% | -$1.33M | 0.02% | 794 |
|
|
2019
Q4 | $23.9M | Sell |
307,251
-50,313
| -14% | -$3.93M | 0.02% | 865 |
|
|
2019
Q3 | $26.2M | Sell |
357,564
-79,107
| -18% | -$5.56M | 0.02% | 773 |
|
|
2019
Q2 | $26.9M | Buy |
436,671
+149,739
| +52% | +$9.05M | 0.02% | 763 |
|
|
2019
Q1 | $18.3M | Buy |
286,932
+138,957
| +94% | +$7.93M | 0.02% | 885 |
|
|
2018
Q4 | $7.55M | Sell |
147,975
-403,245
| -73% | -$20.4M | 0.01% | 1477 |
|
|
2018
Q3 | $32M | Buy |
551,220
+414,672
| +304% | +$20.3M | 0.03% | 584 |
|
|
2018
Q2 | $6.63M | Sell |
136,548
-55,389
| -29% | -$2.59M | 0.01% | 1592 |
|
|
2018
Q1 | $8.93M | Buy |
191,937
+85,767
| +81% | +$3.72M | 0.01% | 1321 |
|
|
2017
Q4 | $3.99M | Sell |
106,170
-118,398
| -53% | -$4.35M | ﹤0.01% | 2055 |
|
|
2017
Q3 | $8.18M | Buy |
224,568
+98,796
| +79% | +$3.77M | 0.01% | 1372 |
|
|
2017
Q2 | $4.96M | Sell |
125,772
-183,468
| -59% | -$6.7M | ﹤0.01% | 1694 |
|
|
2017
Q1 | $9.7M | Buy |
309,240
+273,102
| +756% | +$8.55M | 0.01% | 1153 |
|
|
2016
Q4 | $1.13M | Sell |
36,138
-158,445
| -81% | -$5.13M | ﹤0.01% | 3552 |
|
|
2016
Q3 | $7.82M | Buy |
194,583
+182,682
| +1,535% | +$6.88M | 0.01% | 1272 |
|
|
2016
Q2 | $396K | Sell |
11,901
-40,188
| -77% | -$1.37M | ﹤0.01% | 3886 |
|
|
2016
Q1 | $1.53M | Sell |
52,089
-39,195
| -43% | -$1.08M | ﹤0.01% | 2827 |
|
|
2015
Q4 | $2.4M | Buy |
91,284
+67,626
| +286% | +$1.76M | ﹤0.01% | 2344 |
|
|
2015
Q3 | $561K | Sell |
23,658
-310,230
| -93% | -$7.49M | ﹤0.01% | 3637 |
|
|
2015
Q2 | $7.93M | Buy |
333,888
+82,740
| +33% | +$1.87M | 0.01% | 1378 |
|
|
2015
Q1 | $5.96M | Buy |
251,148
+81,798
| +48% | +$1.84M | 0.01% | 1592 |
|
|
2014
Q4 | $3.6M | Buy |
169,350
+70,104
| +71% | +$1.41M | ﹤0.01% | 2038 |
|
|
2014
Q3 | $1.69M | Sell |
99,246
-57,144
| -37% | -$902K | ﹤0.01% | 2667 |
|
|
2014
Q2 | $2.24M | Sell |
156,390
-11,682
| -7% | -$158K | ﹤0.01% | 2401 |
|
|
2014
Q1 | $2.08M | Sell |
168,072
-513,192
| -75% | -$5.92M | ﹤0.01% | 2332 |
|
|
2013
Q4 | $7.47M | Buy |
681,264
+360,036
| +112% | +$4.06M | 0.01% | 1472 |
|
|
2013
Q3 | $3.73M | Sell |
321,228
-263,976
| -45% | -$3.09M | ﹤0.01% | 2007 |
|
|
2013
Q2 | $6.55M | Buy |
+585,204
| New | +$6.93M | 0.01% | 1399 |
|
Other funds holding EW
VCM
VPM
Citigroup's EW Position: Q1 2026 in Review
Citigroup increased its Edwards Lifesciences (EW) stake by 27% in Q1 2026, buying an estimated $14M and bringing the position to 789,574 shares worth $63.2M. The position accounts for 0.03% of the portfolio, ranked #556.
Citigroup first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $108M in Q2 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Citigroup held 789,574 shares of Edwards Lifesciences worth $63.2M as of Q1 2026.
- Citigroup bought 169,775 Edwards Lifesciences shares in Q1 2026, an estimated $14M.
- Edwards Lifesciences made up 0.03% of Citigroup's portfolio in Q1 2026, its #556 holding.
- Citigroup first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Edwards Lifesciences position peaked at $108M in Q2 2025.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.